It's imperative to identify more HIV-infected women earlier in pregnancy through HIV testing and to reduce mother-to-child transmission of the virus that causes AIDS.
Of course, managing HIV-infected pregnant women doesn't stop with antiretroviral therapy. Patient counseling about treatment before, during, and after childbirth is also critical. And although treating pregnant women and their infants with zidovudine (ZDV) has significantly reduced perinatal transmission of HIV, many potentially preventable infections still occur.
HIV testing The risk of perinatal transmission of HIV-1 has been reduced from 25% to less than 2% for a woman who is aware of her HIV infection early in pregnancy, thanks to antiretroviral therapy and appropriate obstetric intervention. Ideally, ob/gyns should offer all women an HIV test during the first prenatal visit so that those who test positive can begin treatment. The CDC recommends offering all pregnant women voluntary HIV testing not only then, but again to those who initially refuse testing. Also consider repeat testing of high-risk women in the third trimester.
Clinical trial data show that antiretroviral prophylaxis can reduce transmission by up to 50%, even when it's delayed until delivery and given to the newborn 4 To help the greatest number of newborns, routinely offer rapid HIV testing to women whose status is unknown during labor to reduce transmission even among women who wait to seek care until the onset of labor. The rapid HIV test kits now licensed in the US allow test results to be available in less than 20 minutes. Results from the OraQuick Rapid HIV-1 Antibody Test (OraSure Technologies Inc., Bethlehem, Pa.) can be read within 20 to 40 minutes and results from the Reveal Rapid HIV-1 Antibody Test (MedMira Labs Inc., Halifax, Nova Scotia) can be read in roughly 5 to 10 minutes.
The benefits of concurrent fetal and maternal heart rate monitoring
April 15th 2024A recent study revealed that employing maternal heart rate monitoring alongside fetal heart rate monitoring during labor significantly decreases the incidence of neonatal encephalopathy and severe neonatal acidemia.
Read More
How vitamin C intake in pregnant smokers impacts offspring airway function trajectory
April 12th 2024Investigating the impact of prenatal vitamin C supplementation on lung function and wheeze occurrence in offspring of pregnant smokers, revealing insights into mitigating respiratory risks.
Read More
NAID report shows maternal COVID-19 vaccination protects newborns
April 4th 2024New research led by the National Institute of Allergy and Infectious Diseases reveals sustained antibody levels in infants born to vaccinated mothers, underscoring the importance of maternal vaccination in safeguarding newborns against COVID-19.
Read More
FDA grants FTD to nipocalimab for treating FNAIT
March 26th 2024The FDA's Fast Track Designation for nipocalimab marks a significant step in addressing fetal neonatal alloimmune thrombocytopenia risk in pregnant patients, potentially revolutionizing treatment for this severe condition with unmet medical needs.
Read More